Global Nuclear Medicine/Radiopharmaceuticals Sales Market Report 2020

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.

Market Analysis and Insights: Global Nuclear Medicine/Radiopharmaceuticals Market
The global Nuclear Medicine/Radiopharmaceuticals market size is projected to reach US$ 9475.7 million by 2026, from US$ 5915.2 million in 2020, at a CAGR of 8.2% during 2021-2026.

Global Nuclear Medicine/Radiopharmaceuticals Scope and Market Size
The global Nuclear Medicine/Radiopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine/Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Nuclear Medicine/Radiopharmaceuticals market is segmented into
Diagnostic
Therapeutic

Segment by Application, the Nuclear Medicine/Radiopharmaceuticals market is segmented into
Oncology
Thyroid
Cardiology

The Nuclear Medicine/Radiopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Nuclear Medicine/Radiopharmaceuticals market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Nuclear Medicine/Radiopharmaceuticals Market Share Analysis
Nuclear Medicine/Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine/Radiopharmaceuticals business, the date to enter into the Nuclear Medicine/Radiopharmaceuticals market, Nuclear Medicine/Radiopharmaceuticals product introduction, recent developments, etc.

The major vendors covered:
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing